- Report
- November 2023
- 175 Pages
Global
From €4937EUR$5,000USD£4,123GBP
- Report
- November 2023
- 175 Pages
Global
From €4937EUR$5,000USD£4,123GBP
- Report
- November 2023
- 175 Pages
Global
From €4937EUR$5,000USD£4,123GBP
- Report
- November 2023
- 250 Pages
Global
From €4937EUR$5,000USD£4,123GBP
- Report
- November 2023
- 250 Pages
Global
From €4937EUR$5,000USD£4,123GBP
- Report
- August 2024
- 175 Pages
Global
From €3950EUR$4,000USD£3,298GBP
- Report
- January 2024
- 200 Pages
Global
From €3950EUR$4,000USD£3,298GBP
- Report
- October 2024
- 138 Pages
Global
From €2469EUR$2,500USD£2,061GBP
- Report
- October 2024
- 202 Pages
Global
From €2469EUR$2,500USD£2,061GBP
- Report
- October 2024
- 145 Pages
Global
From €2469EUR$2,500USD£2,061GBP
- Report
- July 2024
- 174 Pages
Global
From €2469EUR$2,500USD£2,061GBP
- Report
- July 2024
- 180 Pages
Global
From €2469EUR$2,500USD£2,061GBP
- Report
- July 2024
- 142 Pages
Global
From €2469EUR$2,500USD£2,061GBP
- Report
- May 2024
- 162 Pages
Global
From €2469EUR$2,500USD£2,061GBP
- Report
- May 2024
- 176 Pages
Global
From €2469EUR$2,500USD£2,061GBP
- Report
- February 2024
- 166 Pages
Global
From €2469EUR$2,500USD£2,061GBP
- Report
- January 2024
- 161 Pages
Global
From €2469EUR$2,500USD£2,061GBP
- Report
- December 2023
- 165 Pages
Global
From €2469EUR$2,500USD£2,061GBP
- Report
- May 2024
- 124 Pages
Global
From €3900EUR$3,950USD£3,257GBP
- Report
- April 2024
- 125 Pages
Global
From €3900EUR$3,950USD£3,257GBP
The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more